 |
 |
|
|
Resources for Food and Drug Administration (FDA)Resources > FDA > ArticlesSub-Categories: Listings 1591 - 1600 of 2187:
Imatinib Okayed by FDA for GIST Recurrence
The FDA has given imatinib (Gleevec), the tyrosine kinase that is approved for treating resistant gastrointestinal stromal tumor (GIST), an indication...
Immunomedics drug gets special FDA review program
Biotechnology company Immunomedics Inc. said Thursday the Food and Drug Administration granted the company's developing pancreatic cancer treatment sp...
Immupharma starts separate Lupus trials after US FDA talks
mmupharma PLC said it will start separate phase IIb and phase III trials for its drug IPP-201101 in patients with systemic lupus erythematosus, follow...
Impax Laboratories Inc. Sued by Genzyme Over a Patent Fight
The world's largest maker of drugs for rare genetic disorders, Genzyme Corp. sued Impax Laboratories Inc. for allegedly infringing a patent used for i...
In F.D.A. Files, Claims of Rush to Approve Devices
An official at the Food and Drug Administration overruled front-line agency scientists and approved the sale of an imaging device for breast cancer af...
In milestone, FDA OKs human embryonic stem-cell therapy
In a research milestone, the U.S. government will allow the world's first test in people of a therapy derived from human embryonic stem cells. Federal...
Incalculabe Risk From Children's Toiletries : Reviews
The detailed study of two toxic chemicals found in children's bath and personal care products suggest that if they pose a health hazard, it is likely ...
Incorporating and Funding Security in Information Systems
In this memorandum agencies of the Office of Management and Budget's (OMB) principles are reminded for incorporating and funding security as part of a...
India's Aurobindo Pharma gets U.S. FDA final approval for generic Fosamax
India's Aurobindo Pharma Ltd. said it received final approval from the United States Food and Drug Administration to make and market a generic version...
India's Orchid Chemicals gets FDA nod for generic version of Abbott's Cefdinir
India's Orchid Chemicals & Pharmaceuticals Ltd said it has received approval from the US Food and Drug Administration (FDA) for its Abbreviated New Dr... |
|
RSS Feeds|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2012 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |
 |
 |